Mounier, Nicolas <br/><br/>
Estimating the impact of rituximab on bcl-2-associated resistance to CHOP in elderly patients with diffuse large B-cell lymphoma.  [electronic resource] 

 -  Haematologica  May 2006 
 - 715-6 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, bcl-2<br/>Humans<br/>Immunotherapy<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Middle Aged<br/>Multicenter Studies as Topic--statistics & numerical data<br/>Neoplasm Proteins--genetics<br/>Prednisone--administration & dosage<br/>Proportional Hazards Models<br/>Proto-Oncogene Proteins c-bcl-2--physiology<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Risk<br/>Rituximab<br/>Survival Analysis<br/>Vincristine--administration & dosage